Align Technology (ALGN) Stock Price, News & Analysis

Company Overview

Align Technology, Inc. develops, manufactures and markets digital orthodontic and restorative dentistry products. Its best-known offering is the Invisalign system, which uses a series of custom-made clear aligners to straighten teeth. The company also sells Vivera retainers and iTero intraoral scanners, which support digital dental imaging and treatment planning.

Founded in 1997, Align helped popularize clear-aligner orthodontic treatment as an alternative to traditional braces. Its digital dentistry portfolio also includes exocad software, used by dental professionals and laboratories to design dental restorations.

Headquartered in Tempe, Arizona, Align serves dental professionals and patients in markets around the world. Joe Hogan has served as the company’s president and chief executive officer since 2015.

Key Stats

• Today's Range: $171.00 to $175.81
• 50-Day Range: $139.87 to $174.26
• 52-Week Range: $130.23 to $200.43
• Volume: 1.91 million shs
• Average Volume: 1.16 million shs
• Market Capitalization: $12.28 billion
• P/E Ratio: 25.37
• Dividend Yield: N/A
• Price Target: $193.08
• Consensus Rating: Moderate Buy

Align Technology Stock Analysis - MarketRank™

Align Technology scored higher than 71% of companies evaluated by MarketBeat, and ranked 267th out of 881 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.1 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Align Technology has received a consensus rating of Moderate Buy. The company's average rating score is 2.53, and is based on 1 strong buy rating, 8 buy ratings, 7 hold ratings, and 1 sell rating.

Upside Potential

Align Technology has a consensus price target of $193.08, representing about 10.8% upside from its current price of $174.26.

Amount of Analyst Coverage

Align Technology has been the subject of 11 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 11.51%

Earnings Growth

Earnings for Align Technology are expected to grow by 11.51% in the coming year, from $9.21 to $10.27 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Align Technology is 25.37, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.82.

Price to Earnings Ratio vs. Sector

The P/E ratio of Align Technology is 25.37, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 35.24.

Price to Earnings Growth Ratio

Align Technology has a PEG Ratio of 1.89. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Align Technology has a P/B Ratio of 2.85. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

5.87% of the float of Align Technology has been sold short.

Short Interest Ratio / Days to Cover

Align Technology has a short interest ratio ("days to cover") of 3.95, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Align Technology has recently decreased by 0.92%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Align Technology does not currently pay a dividend.

Dividend Growth

Align Technology does not have a long track record of dividend growth.

News and Social Media

• Score: 3.2 / 5
• News Sentiment: 1.11

News Sentiment

Align Technology has a news sentiment score of 1.11. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.57 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 17 news articles for Align Technology this week, compared to 7 articles on an average week.

Search Interest

Only 2 people have searched for ALGN on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.

MarketBeat Follows

Only 1 people have added Align Technology to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

Company Ownership

• Score: 0.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Align Technology insiders have not sold or bought any company stock.

Percentage Held by Insiders

0.75% of the stock of Align Technology is held by insiders.

Percentage Held by Institutions

88.43% of the stock of Align Technology is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 10/28/2026
• Today: 11/11/2026
• Jefferies Global Healthcare Conference: 11/17/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Supplies
• Current Symbol: NASDAQ:ALGN
• CIK: 1097149
• Web: www.aligntech.com
• Phone: (408) 470-1000
• Fax: 408-470-1010
• Employees: 20,290
• Year Founded: 1997

Price Target and Rating

• Average Price Target for Align Technology: $193.08
• High Price Target: $240.00
• Low Price Target: $155.00
• Potential Upside/Downside: +10.8%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.53
• Research Coverage: 17 Analysts

Profitability

• EPS (Trailing Twelve Months): $6.87
• Trailing P/E Ratio: 25.37
• Forward P/E Ratio: 16.97
• P/E Growth: 1.89
• Net Income: $410.35 million
• Net Margins: 11.83%
• Pretax Margin: 15.49%
• Return on Equity: 15.96%
• Return on Assets: 10.48%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.42
• Quick Ratio: 1.31

Sales & Book Value

• Annual Sales: $4.03 billion
• Price / Sales: 3.04
• Cash Flow: $11.87 per share
• Price / Cash Flow: 14.68
• Book Value: $61.08 per share
• Price / Book: 2.85

Miscellaneous

• Outstanding Shares: 70,490,000
• Free Float: 69,958,000
• Market Cap: $12.28 billion
• Optionable: Optionable
• Beta: 1.74